Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications

Rev Endocr Metab Disord. 2010 Mar;11(1):61-74. doi: 10.1007/s11154-010-9134-4.

Abstract

Cardiovascular disease is a major complication of diabetes mellitus, and improved strategies for prevention and treatment are needed. Endothelial dysfunction contributes to the pathogenesis and clinical expression of atherosclerosis in diabetes mellitus. This article reviews the evidence linking endothelial dysfunction to human diabetes mellitus and experimental studies that investigated the responsible mechanisms. We then discuss the implications of these studies for current management and for new approaches for the prevention and treatment of cardiovascular disease in patients with diabetes mellitus.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Atherosclerosis / etiology
  • Atherosclerosis / physiopathology
  • Cardiovascular Diseases / etiology*
  • Diabetes Mellitus / physiopathology*
  • Endothelium, Vascular / physiopathology*
  • Humans
  • Inflammation / etiology
  • Inflammation / physiopathology
  • Insulin Resistance / physiology
  • Mitochondria / physiology
  • Nitric Oxide / biosynthesis
  • Nitric Oxide / physiology
  • Nitric Oxide Synthase Type III / physiology
  • Oxidative Stress
  • Phosphatidylinositol 3-Kinases / metabolism
  • Protein Kinase C / metabolism
  • Protein Kinase C beta
  • Signal Transduction / physiology

Substances

  • Nitric Oxide
  • NOS3 protein, human
  • Nitric Oxide Synthase Type III
  • Phosphatidylinositol 3-Kinases
  • Protein Kinase C
  • Protein Kinase C beta